Page last updated: 2024-08-16

terfenadine and levocabastine

terfenadine has been researched along with levocabastine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (85.71)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Blockhuys, S; Janssens, M; Parys, W1
Bahmer, FA1
Blockhuys, S; Janssens, M1
Bahmer, FA; Ruprecht, KW1
Freng, BA; Garud, O; Korsrud, FR; Kramer, J; Olsen, AK; Poppe, S; Rebo, R; Søhoel, P; Woxen, OJ1

Reviews

2 review(s) available for terfenadine and levocabastine

ArticleYear
New trends in the treatment of allergic conjunctivitis.
    Documenta ophthalmologica. Advances in ophthalmology, 1992, Volume: 82, Issue:4

    Topics: Animals; Antazoline; Conjunctivitis, Allergic; Cromolyn Sodium; Histamine H1 Antagonists; Humans; Naphazoline; Ophthalmic Solutions; Piperidines; Placebos; Terfenadine

1992
Topical levocabastine--an effective alternative to oral antihistamines in seasonal allergic rhinoconjunctivitis.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1995, Volume: 25, Issue:3

    Topics: Administration, Oral; Administration, Topical; Clinical Trials as Topic; Conjunctivitis, Allergic; Double-Blind Method; Histamine H1 Antagonists; Humans; Loratadine; Piperidines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Seasonal; Terfenadine

1995

Trials

5 trial(s) available for terfenadine and levocabastine

ArticleYear
New trends in the treatment of allergic conjunctivitis.
    Documenta ophthalmologica. Advances in ophthalmology, 1992, Volume: 82, Issue:4

    Topics: Animals; Antazoline; Conjunctivitis, Allergic; Cromolyn Sodium; Histamine H1 Antagonists; Humans; Naphazoline; Ophthalmic Solutions; Piperidines; Placebos; Terfenadine

1992
A comparison of topical levocabastine and oral terfenadine in the treatment of allergic rhinoconjunctivitis. The Livostin Study Group.
    Allergy, 1993, Volume: 48, Issue:7

    Topics: Administration, Intranasal; Administration, Oral; Adult; Conjunctivitis, Allergic; Double-Blind Method; Histamine H1 Antagonists; Humans; Ophthalmic Solutions; Piperidines; Rhinitis, Allergic, Seasonal; Terfenadine

1993
Tolerability of levocabastine eye drops.
    Documenta ophthalmologica. Advances in ophthalmology, 1993, Volume: 84, Issue:2

    Topics: Adolescent; Adult; Conjunctivitis, Allergic; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Histamine H1 Antagonists; Humans; Male; Ophthalmic Solutions; Piperidines; Terfenadine; Visual Acuity

1993
Safety and efficacy of topical levocabastine compared with oral terfenadine.
    Annals of allergy, 1994, Volume: 72, Issue:5

    Topics: Administration, Oral; Administration, Topical; Adult; Conjunctivitis, Allergic; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Ophthalmic Solutions; Piperidines; Rhinitis, Allergic, Seasonal; Terfenadine

1994
Topical levocabastine compared with orally administered terfenadine for the prophylaxis and treatment of seasonal rhinoconjunctivitis.
    The Journal of allergy and clinical immunology, 1993, Volume: 92, Issue:1 Pt 1

    Topics: Administration, Oral; Adult; Aerosols; Conjunctivitis, Allergic; Double-Blind Method; Drug Tolerance; Female; Histamine H1 Antagonists; Humans; Male; Norway; Ophthalmic Solutions; Piperidines; Remission Induction; Rhinitis, Allergic, Seasonal; Terfenadine

1993

Other Studies

1 other study(ies) available for terfenadine and levocabastine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004